Resmed CDI (ASX:RMD)
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) share price news
Near $200 – Are Cochlear (ASX:COH) Shares Finally Cheap?
Cochlear Limited (ASX:COH) shares were down 4% today following their Annual General Meeting (AGM). Is it time to buy Cochlear shares?
Better Buy: ResMed (ASX:RMD) Or Ramsay Health Care (ASX:RHC)?
If you’re looking for growth in your portfolio, you may have considered ResMed Inc (ASX: RMD) or Ramsay Health Care Limited (ASX: RHC). Here’s which one I would pick.
Why The ResMed (ASX:RMD) Share Price Jumped 5%
ResMed Inc (ASX:RMD) announced the fourth quarter result of its 2019 financial year.
ALL ORDINARIES Index (XAO) Down, Appen (ASX:APX) Share Price Down
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 0.32% at lunch.
2 Ethical ASX ETFs Kicking Goals
The BetaShares Global Sustainability Leaders ETF (ASX:ETHI) and the BetaShares Australian Sustainability Leaders ETF (ASX:FAIR) are two options.
2 ASX Healthcare Shares To Bolster Your Portfolio
The healthcare industry benefits from an ageing population. I look at two ASX shares, ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL).
Can Cochlear (COH) Shares Reach $220 Again?
The 52-week high price for Cochlear Limited (ASX: COH) shares is $221.44. Up almost 20% in the last three months, could Cochlear reach these highs again?
My Top 3 ASX Healthcare Shares… And CSL Ltd
Forget CSL shares, Cochlear Ltd (ASX: COH), Nanosonics Ltd (ASX:NAN) and ResMed Inc (ASX:RMD) shares are amongst my top three ASX healthcare shares.
The ResMed (ASX: RMD) Share Price Is Going Nuts
The ResMed Inc. (ASX:RMD) share price is up as much as 10.5% to a high of $16.25 after handing down the third quarter results with revenue up 12%.